South Korea Metagenomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (Shotgun Sequencing and Whole Genome Sequencing), By Product (Kits & Reagents, Sequencing & Data Analytics Services, and Software), and South Korea Metagenomics Market Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jul 2025
REPORT ID SI13990
PAGES 180
REPORT FORMAT PathSoft

South Korea Metagenomics Market Insights Forecasts to 2035

  • The South Korea Metagenomics Market Size Was Estimated at USD 28.54 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 13.79% from 2025 to 2035
  • The South Korea Metagenomics Market Size is Expected to Reach USD 118.2 Million by 2035

South Korea Metagenomics Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Metagenomics Market Size is Anticipated to Reach USD 118.2 Million by 2035, Growing at a CAGR of 13.79% from 2025 to 2035. The usage of metagenomics in a variety of applications is expected to increase as sequencing costs decrease.  As such, numerous national and international genome initiatives have been launched in recent years.  The market expansion is expected to be supported by strategic initiatives implemented by businesses and academic institutions to develop cutting-edge technology.

 

Market Overview

The metagenomics market involves the study of genetic material recovered directly from environmental or clinical samples, enabling analysis of microbial communities without the need for culturing. This approach offers significant benefits, including comprehensive insights into microbial diversity, detection of novel organisms, and understanding of microbiome-related health and environmental conditions. Metagenomics is widely used in infectious disease diagnostics, agriculture, biotechnology, and environmental monitoring. The expanding with advancements in sequencing technologies and bioinformatics tools. In South Korea, government initiatives supporting genomic research, bioindustry innovation, and precision medicine are accelerating metagenomics adoption.

 

Report Coverage

This research report categorizes the market for South Korea metagenomics market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea metagenomics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea metagenomics market.

 

South Korea Metagenomics Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 28.54 Million
Forecast Period:2024-2035
Forecast Period CAGR 2024-2035 :13.79%
2035 Value Projection:USD 118.2 Million
Historical Data for:2020-2023
No. of Pages:180
Tables, Charts & Figures:150
Segments covered:By Technology, By Product and COVID-19 Impact Analysis.
Companies covered:: Macrogen Inc., GeneMatrix Inc., PSOMAGEN Inc., Bertis Inc., BIOINFRA Inc., Seegene Inc., CJ Bioscience, Lotte Biologics, Samsung Biologics, SK Bioscience, Thermo Fisher Scientific Korea and Others.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The rapid advancements in next-generation sequencing (NGS) technologies have made microbial genome analysis faster, more accurate, and cost-effective. The growing demand for personalized medicine, infectious disease diagnostics, and microbiome-based therapies is expanding clinical applications. Additionally, metagenomics is increasingly used in agriculture, environmental monitoring, and food safety.

 

Restraining Factors

The hinder its growth and widespread adoption. Despite advancements in sequencing technologies, the high costs associated with acquiring and maintaining sophisticated equipment remain a substantial barrier, particularly for research institutions in developing regions.

 

Market Segmentation

The South Korea metagenomics market share is classified into technology and product.

 

  • The shotgun sequencing segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea metagenomics market is segmented by technology into shotgun sequencing and whole genome sequencing. Among these, the shotgun sequencing segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Shotgun sequencing ability to comprehensively analyse complex microbial communities without prior knowledge of organisms. This method enables high-throughput, unbiased sequencing of all genetic material in a sample, making it ideal for environmental, clinical, and agricultural applications. Advances in sequencing technology have reduced costs and improved accuracy, increasing adoption.

 

  • The kits & reagents segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea metagenomics market is segmented by product into kits & reagents, sequencing & data analytics services, and software. Among these, the kits & reagents segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The essential role these products play in sample preparation and accurate sequencing. Growing demand for user-friendly, standardized kits supports efficient workflows and reliable results in research and clinical diagnostics. Advances in reagent quality and availability, combined with increasing genomic and microbiome research activities, drive strong adoption.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea metagenomics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Macrogen Inc.
  • GeneMatrix Inc.
  • PSOMAGEN Inc.
  • Bertis Inc.
  • BIOINFRA Inc.
  • Seegene Inc.
  • CJ Bioscience
  • Lotte Biologics
  • Samsung Biologics
  • SK Bioscience
  • Thermo Fisher Scientific Korea
  • Others

 

Recent Developments:

  • In June 2025, As the capital and largest city, Seoul is the heart of South Korea’s political, economic, and cultural activities. It is home to global tech giants like Samsung and LG and leads in finance, innovation, and K-culture. The city is also known for its smart infrastructure and dynamic urban lifestyle.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea metagenomics market based on the below-mentioned segments:

 

South Korea Metagenomics Market, By Technology

  • Shotgun Sequencing
  • Whole Genome Sequencing

 

South Korea Metagenomics Market, By Product

  • Kits & Reagents
  • Sequencing & Data Analytics Services
  • Software

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies